SCHEMBL16769883

SCHEMBL16769883

Cc1ccc(/C=C2\CN(Cc3ccccc3)C/C(=C\c3ccc(C)cc3)C2=O)cc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 8/20 0.78
ALDH1A1 P00352 3/20 0.74
MAPT P10636 3/20 0.74
LMNA P02545 3/20 0.74
KMT2A Q03164 3/20 0.74
MAPK1 P28482 2/20 0.74
KDM4E B2RXH2 1/20 0.74
BCHE P06276 2/20 0.68
PTGS2 P35354 1/20 0.68
CARM1 Q86X55 4/20 0.62
RAB9A P51151 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
TP53 P04637 1/20 0.62
HTT P42858 1/20 0.62
PAX8 Q06710 2/20 0.61
MEN1 O00255 2/20 0.61
NPC1 O15118 1/20 0.61
P4HB P07237 1/20 0.61
GAA P10253 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16755537 1.00 ACHE (0.78) ACHEALDH1A1MAPTLMNAKMT2A
SCHEMBL16755540 1.00 ACHE (0.78) ACHEALDH1A1MAPTLMNAKMT2A
SCHEMBL19629172 0.90 ACHE (0.74) ACHEALDH1A1MAPTLMNAKMT2A
SCHEMBL16769905 0.87 ALDH1A1 (0.72) ACHEALDH1A1MAPTLMNAKMT2A
SCHEMBL15562489 0.87 ALDH1A1 (0.72) ACHEALDH1A1MAPTLMNAKMT2A
SCHEMBL15562491 0.87 ALDH1A1 (0.72) ACHEALDH1A1MAPTLMNAKMT2A
SCHEMBL16769899 0.87 ALDH1A1 (0.71) ACHEALDH1A1MAPTLMNAKMT2A
SCHEMBL16755530 0.87 ALDH1A1 (0.71) ACHEALDH1A1MAPTLMNAKMT2A
Dimethylamine SCHEMBL8372682 0.87 ACHE (0.71) ACHEALDH1A1MAPTLMNAKMT2A
SCHEMBL16755532 0.87 ALDH1A1 (0.71) ACHEALDH1A1MAPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200399220-A1 3,5-DIARYLIDENYL-N-SUBSTITUTED-PIPERID-4-ONE-DERIVED INHIBITORS OF STAT3 PATHWAY ACTIVITY AND USES THEREOF KIAKOS KONSTANTINOS (AT) 2020-12-24 US disclosed
US-9884825-B2 Curcumin analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2018-02-06 US disclosed
US-9884825-B2 Curcumin analogs and methods of making and using thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2018-02-06 US disclosed
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof UNIVERSITY OF DELHI (IN) 2015-06-04 US disclosed
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof UNIVERSITY OF DELHI (IN) 2015-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150152056-A1 Curcumin Analogs and Methods of Making and Using Thereof COX15, HCCS, HMOX2 ACHE 3174/4885ALDH1A1 94/4885MAPT 3159/4885
US-20200399220-A1 3,5-DIARYLIDENYL-N-SUBSTITUTED-PIPERID-4-ONE-DERIVED INHIBITORS OF STAT3 PATHWAY ACTIVITY AND USES THEREOF STAT3, JAK2, STAT6 ACHE 4849/4885ALDH1A1 928/4885MAPT 4414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.